Managing postoperative pain after robotic surgery for pelvic organ prolapse
Effect of Quadratus Lumborum (QL) Block in Postoperative Pain Management Following Robotic Assisted Sacrocolpopexy
This study is testing whether a special nerve block can help women feel less pain after robotic surgery for pelvic organ prolapse compared to a standard recovery plan.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Trial ID | NCT06309693 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of a quadratus lumborum (QL) nerve block compared to the Enhanced Recovery After Surgery (ERAS) protocol in managing postoperative pain for women undergoing robotic-assisted sacrocolpopexy. Participants will be randomized into two groups: one receiving the QL block and the other following the ERAS protocol alone. The study will assess various outcomes, including patient-reported pain scores, opioid consumption, and rates of postoperative nausea and vomiting. The goal is to identify a more effective pain management strategy that minimizes opioid use and enhances recovery.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 and older who are undergoing robotic-assisted sacrocolpopexy, with or without concurrent hysterectomy.
Not a fit: Patients who are not fluent or literate in English will not benefit from this study due to the requirement for informed consent and understanding of the study procedures.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies that reduce opioid dependency and enhance recovery for patients undergoing pelvic surgery.
How similar studies have performed: Other studies have shown promise in using nerve blocks for postoperative pain management, suggesting that this approach may be effective, though the specific application in this context is still being evaluated.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women undergoing robotic-assisted sacrocolpopexy with concurrent robotic assisted supracervical or total laparoscopic hysterectomy or robotic assisted sacrocolpopexy after previous hysterectomy 2. Age 18 years old or greater 3. Fluency and literacy in English 4. Capacity to provide consent Exclusion Criteria: 1. Lack fluency and literacy in English
Where this trial is running
Birmingham, Alabama
- University of Alabama at Birmingham — Birmingham, Alabama, United States (Recruiting)
Study contacts
- Study coordinator: Katelyn Donaldson, MD
- Email: katelyndonaldson@uabmc.edu
- Phone: 205-996-7372
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.